ONCE Insider Trading Activity and SEC Form 4 Filings
ONCE insider trading summary
No open-market insider purchases or sales of Spark Therapeutics, Inc. (ONCE) have been reported on SEC Form 4 in the past 12 months.
Latest ONCE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 27, 2019 | Children's Hospital of Philadelphia Foundation | 10% Owner | Sell | $226.0M (2,000,000 @ $113.00) |
| Apr 20, 2018 | John Furey | Chief Operating Officer | Sell | $555K (6,723 @ $82.50) |
| Apr 18, 2018 | John Furey | Chief Operating Officer | Sell | $908K (11,000 @ $82.53) |
| Apr 17, 2018 | John Furey | Chief Operating Officer | Sell | $188K (2,277 @ $82.50) |
| Apr 12, 2018 | John Furey | Chief Operating Officer | Sell | $1.6M (20,000 @ $77.51) |
| Dec 11, 2017 | John Furey | Chief Operating Officer | Sell | $834 (18 @ $46.33) |
| Dec 8, 2017 | John Furey | Chief Operating Officer | Buy | $1K (18 @ $73.48) |
| Nov 28, 2017 | Katherine A High | See Remarks | Sell | $108K (1,500 @ $72.27) |
| Nov 28, 2017 | Elliot Sigal | Director | Sell | $2K (29 @ $72.43) |
| Nov 28, 2017 | Katherine A High | See Remarks | Sell | $248K (3,500 @ $70.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.